Insight Molecular Diagnostics Inc.
NASDAQ:IMDX · NASDAQ Capital Market
+$0.13 today
Vol 0.69M · Avg 0.38M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+48.63%
Period High
$8.48
Period Low
$2.40
Latest
$5.44
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Cybin Inc.
CYBN
$413.02M
C4 Therapeutics, Inc.
NASDAQ:CCCC
$335.16M
Prelude Therapeutics Incorporated
NASDAQ:PRLD
$329.69M
OmniAb, Inc.
NASDAQ:OABI
$258.43M
Armata Pharmaceuticals, Inc.
AMEX:ARMP
$254.77M
Codexis, Inc.
NASDAQ:CDXS
$226.88M
Invivyd, Inc.
NASDAQ:IVVD
$128.75M
PepGen Inc.
NASDAQ:PEPG
$124.85M
Milestone Pharmaceuticals Inc.
NASDAQ:MIST
$112.51M
Sangamo Therapeutics, Inc.
NASDAQ:SGMO
$70.88M
What is the latest IMDX filing?
The latest filing shown is 8-K dated Jun 17, 2026.
How many recent filings does IMDX have?
Intrinsic Alpha currently shows 20 recent filings for IMDX.
Explore More
Continue the stock analysis
Jump to another research area for this company.